Dendreon Announces Senior Management Change
"We are grateful for Marty's contributions to the growth and development of our business during his more than six years at Dendreon, particularly with respect to successful fund raising and sound financial management," said Mitchell H. Gold, M.D., Dendreon's president and chief executive officer. "Marty has worked diligently to meet the many new requirements of corporate governance, including those of the Sarbanes-Oxley Act. I want to thank Marty for his contributions and wish him the very best for the future."
"I am pleased to have been a member of the executive management team at Dendreon and to have been intimately involved in the growth of the business," said Mr. Simonetti. "The finance organization is solid and will be a key part of the foundation for the next phase of Dendreon's growth. I am looking forward to spending some time with my family and to the next phase of my career."
The Company has initiated a search for the position.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.